scholarly journals Case Report: Biologic Graft Placement with Subsequent Radiation Therapy Following Radical Vulvectomy for Adenoid Cystic Carcinoma of the Bartholin’s Gland

2021 ◽  
pp. 100736
Author(s):  
Keely Ulmer ◽  
Megan E. McDonald ◽  
Joseph T. Kowalski
Keyword(s):  
Radiation Therapy ◽  
Case Report ◽  
Adenoid Cystic Carcinoma ◽  
Biologic Graft ◽  
Graft Placement ◽  
Adenoid Cystic ◽  
Bartholin’S Gland ◽  
Radical Vulvectomy

scholarly journals Adenoid Cystic Carcinoma of Bartholin's Gland: A Case Report

2005 ◽  
Vol 44 (1) ◽  
pp. 72-74 ◽  
Author(s):  
Fang-Yu Hung ◽  
Kung-Liahng Wang ◽  
Tao-Yeuan Wang
Keyword(s):  
Case Report ◽  
Adenoid Cystic Carcinoma ◽  
Adenoid Cystic ◽  
Bartholin’S Gland

scholarly journals Adenoid cystic carcinoma of the Bartholin’s gland: a case report and literature review

2019 ◽  
Vol 48 (2) ◽  
pp. 030006051986354 ◽  
Author(s):  
Yanan Chang ◽  
Wang Wu ◽  
Hong Chen
Keyword(s):  
Case Report ◽  
Adenoid Cystic Carcinoma ◽  
Gold Standard ◽  
Clinical Manifestations ◽  
Surgical Excision ◽  
Diagnosis And Treatment ◽  
Adenoid Cystic ◽  
Bartholin’S Gland ◽  
Gynecological Examination ◽  
Low Incidence

Objective The present study was performed to explore the clinical features, diagnosis, and treatment of adenoid cystic carcinoma of the Bartholin’s gland. Methods The clinical data of a case of adenoid cystic carcinoma of the Bartholin’s gland were examined, and the clinical manifestation, diagnosis, and treatment were analyzed. Results Adenoid cystic carcinoma of the Bartholin’s gland has a low incidence. The main clinical manifestations are vulvar lumps, dyspareunia, pain, itching, and bleeding. The diagnosis is based on gynecological examination and pathological biopsy, and the treatment is mainly surgical excision. Conclusion Adenoid cystic carcinoma of the Bartholin’s gland is rare and lacks specificity. Pathological biopsy is the gold standard for diagnosis, and surgical resection should be performed for treatment.

scholarly journals Brain and lung metastasis of Bartholin’s gland adenoid cystic carcinoma: a case report

2013 ◽  
Vol 7 (1) ◽  
Author(s):  
Rajeev Ramanah ◽  
Edith Allam-Ndoul ◽  
Claire Baeza ◽  
Didier Riethmuller
Keyword(s):  
Case Report ◽  
Adenoid Cystic Carcinoma ◽  
Lung Metastasis ◽  
Adenoid Cystic ◽  
Bartholin’S Gland

scholarly journals Cutaneous adenoid cystic carcinoma of lower eyelid: Case report of a rare malignant entity

2021 ◽  
pp. 102467
Author(s):  
Salissou Iro ◽  
Mohamed Raiteb ◽  
Amina Maadane ◽  
Sanaa Elmrini ◽  
Faiçal Slimani
Keyword(s):  
Case Report ◽  
Adenoid Cystic Carcinoma ◽  
Lower Eyelid ◽  
Adenoid Cystic

Patterns of Care and Outcomes of Primary Adenoid Cystic Carcinoma of the Trachea

2021 ◽  
pp. 000348942110081
Author(s):  
Sara Behbahani ◽  
Gregory L. Barinsky ◽  
David Wassef ◽  
Boris Paskhover ◽  
Rachel Kaye
Keyword(s):  
Radiation Therapy ◽  
Adenoid Cystic Carcinoma ◽  
Surgical Resection ◽  
Proportional Hazards ◽  
Invasive Disease ◽  
Cox Proportional Hazards ◽  
Tumor Diameter ◽  
Adenoid Cystic ◽  
Cox Proportional Hazards Models ◽  
Age Of Diagnosis

Objective: Primary tracheal malignancies are relatively rare cancers, representing 0.1% to 0.4% of all malignancies. Adenoid cystic carcinoma (ACC) is the second most common histology of primary tracheal malignancy, after squamous cell carcinoma. This study aims to analyze demographic characteristics and potential influencing factors on survival of tracheal ACC (TACC). Methods: This was a retrospective cohort study utilizing the National Cancer Database (NCDB). The NCDB was queried for all cases of TACC diagnosed from 2004 to 2016 (n = 394). Kaplan-Meier (KM) and Cox proportional-hazards models were used to determine clinicopathological and treatment factors associated with survival outcomes. Results: Median age of diagnosis was 56 (IQR: 44.75-66.00). Females were affected slightly more than males (53.8% vs 46.2%). The most prevalent tumor diameter range was 20 to 39 mm (34.8%) followed by greater than 40 mm in diameter (17.8%). Median overall survival (OS) was 9.72 years with a 5- and 10-year OS of 70% and 47.5%, respectively. Localized disease was not associated with a survival benefit over invasive disease ( P = .388). The most common intervention was surgery combined with radiation therapy (RT) at 46.2%, followed by surgery alone (16.8%), and standalone RT (8.9%). When adjusting for confounders, surgical resection was independently associated with improved OS (HR 0.461, 95% CI 0.225-0.946). Tumor size greater than 40 mm was independently associated with worse OS (HR 2.808; 95% CI 1.096-7.194). Conclusion: Our data suggests that surgical resection, possibly in conjunction with radiation therapy, is associated with improved survival, and tumor larger than 40 mm are associated with worse survival.

Sign in / Sign up

Export Citation Format

Share Document